Liver Fibrosis Market Size is projected to reach USD 38.74 billion

WHAT IS LIVER FIBROSIS MARKET?

According to data from Data Bridge Market Research, the liver fibrosis market was estimated to be worth USD 16.45 billion in 2021 and is projected to grow to USD 38.74 billion by 2029, showing a CAGR of 11.30% from 2022 to 2029. The Data Bridge Market Research team's thorough expert research, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework are all included in the market report.

Liver Fibrosis Market survey report has been formulated with the scrupulous efforts of an innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry experts, and forecasters. Market-related variables incorporated in this business research report such as current market trends, market division, new market section, industry anticipation, future bearings, opportunity analysis, key examination and arranging, target market, experiences and advancement in technology assist the organization to grow and expand in the current market scenario. For the clear and better understanding of facts and figures, the data is represented in the form of graphs and charts throughout Liver Fibrosis Market document.

Access PDF Sample Report (Including Graphs, Charts Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-liver-fibrosis-market

Market Definition

Repeated or persistent liver damage results in an unusually high quantity of scar tissue in the liver, which is known as liver fibrosis. Fibrosis has no symptoms, but extensive scarring causes cirrhosis, which causes symptoms. Healthcare providers use blood and imaging tests to determine the severity of the condition, and liver biopsy. Healthcare practitioners focus on treating the source of liver fibrosis, which often stops or slows additional scarring of the liver and leads to a better outcome. Antiviral medications and the removal or dissolution of a blockage in the bile ducts, are all potential treatments for liver fibrosis.

COVID-19 Impact on Liver Fibrosis Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The supply chain slowness hampered the liver fibrosis market.

Recent Development

In January 2022, Siemens Healthineers announced the launch of the Enhanced Liver Fibrosis (ELF) Test in the U.S. this test offers broad clinical access to the minimally invasive prognostic tool. The ELF Test is a simple, efficient blood test for determining prognosis in individuals with advanced fibrosis (F3 or F4) caused by non-alcoholic steatohepatitis (NASH), a kind of non-alcoholic fatty liver disease (NAFLD) characterized by liver inflammation.

LIVER FIBROSIS MARKET SEGMENTATION-

Condition

Chronic Liver Diseases
Hepatitis C
Nonalcoholic Steatohepatitis

Route of Administration

Oral
Parenteral
Others

Diagnosis

Nonsurgical Tests
Transient Elastography
Liver Biopsy
Others

Treatment

Peroxisome Proliferator-activated Receptors (PPAR)-alpha agonist
ACE Inhibitors
Hepatotropic Drug
Others

End-Users

Hospitals
Specialty Clinics
Homecare
Others

Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

KEY POINTERS COVERED IN GLOBAL LIVER FIBROSIS MARKET INDUSTRY TRENDS AND FORECAST TO 2029

Market Size
Market New Sales Volumes
Market Replacement Sales Volumes
Market Installed Base
Market By Brands
Market Procedure Volumes
Market Product Price Analysis
Market Cost of Care Analysis
Market Shares in Different Regions
Recent Developments for Market Competitors
Market Upcoming Applications
Market Innovators Study

KEY MARKET COMPETITORS COVERED IN THE REPORT

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd.(Israel)
Sanofi (France)
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
AstraZeneca (UK)
Johnson Johnson Private Limited (US)
Sun Pharmaceutical Industries Ltd. (India)
Merck Co., Inc. (US)
Bristol-Myers Squibb Company (US)
Gilead Sciences, Inc. (US)
Vertex Pharmaceuticals Incorporated (US)
FibroGen, Inc. (US)
Pharmaxis Ltd (Australia)
Dicerna Pharmaceuticals, Inc. (US)
Dynavax Technologies (US)

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-liver-fibrosis-market

BASIC QUESTIONS ASKED

Which companies dominate the Liver Fibrosis Market globally?
What factors might prevent the worldwide market from growing throughout the expected time period?
Which geographic market offers the most enticing growth opportunities for companies that operate in this sector?
Which are the factors driving the Liver Fibrosis Market during the forecast period?
What is the expected market value of the Liver Fibrosis Market during the forecast period?

LIVER FIBROSIS MARKET COUNTRY LEVEL ANALYSIS

The countries covered in the Liver Fibrosis Market report are
U.S.
Canada
and Mexico in North America
Germany
France
U.K.
Netherlands
Switzerland
Belgium
Russia
Italy
Spain
Turkey
Rest of Europe in Europe
China
Japan
India
South Korea
Singapore
Malaysia
Australia
Thailand
Indonesia
Philippines
Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
Saudi Arabia
U.A.E
South Africa
Egypt
Israel

MAJOR TOC OF THE REPORT

Introduction
Market Segmentation
Executive Summary
Premium Insight
Market Overview
Covid-19 Impact on Tracheostomy Products in Healthcare Industry
Liver Fibrosis Market, by Product Type
Liver Fibrosis Market, by Modality
Liver Fibrosis Market, by Type
Liver Fibrosis Market, by Mode
Liver Fibrosis Market, by End User
Liver Fibrosis Market, by Geography
Liver Fibrosis Market, Company Landscape
Swot Analysis
Company Profiles
Related Reports

Get TOC Details- https://www.databridgemarketresearch.com/toc/?dbmr=global-liver-fibrosis-market

BROWSE RELATED REPORTS@

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

Liver Fibrosis Market Size is projected to reach USD 38.74 billion

COVID-19 Impact on Liver Fibrosis Market

TRENDS

VP Smart Removals

2023 NFL Draft Seahawks full return for Russell Wilson revealed after making final pick in the second round

What Are the Essential Safety Features Every Golf Cart Should Have?